Pulled from the Infectious Economics archives, these articles provide recommendations for the design and development of robust mathematical models of COVID-19 epidemiology and economics to reduce uncertainty in decision-making and inform evidence-based public policy. Associations are easy; valid causal inference is hard Tutorial: how to estimate person-centered treatment effects so that public policy to control … Continue reading Advanced methods for math modeling the epidemiology and economics of coronavirus
Think about the last time you were forced to make a decision in the face of uncertainty. You may have been choosing which job offer to accept or whether to move from renting to buying a home. You probably weighed the tradeoffs and asked yourself whether it made sense to gather additional information or to … Continue reading Do FDA alerts impact practice patterns?
The Flatiron study is proof of principle that real world evidence can be used to examine and inform health policy interventions, said Zafar, who led a discussion of Adamson’s study at the ASCO plenary session. Continue reading How to lead a research team from #hackathon to plenary in 6 months
One of the most highly infectious time periods in the life of a person with HIV is also when that person is most likely unaware of their HIV status. This is the acute stage. Shortly after infection, the virus explodes with a measurable peak in the number of copies floating around. This feature of the … Continue reading Do the math: Finding acute HIV cases in a hot epidemic
Adamson spoke with Matthew Ong, a reporter with The Cancer Letter Before 2019, Blythe Adamson, a senior quantitative scientist at Flatiron Health, had never attended an annual meeting of the American Society of Clinical Oncology. In the shower, sometime in November 2018, Adamson came up with an idea for future research: “I think we should … Continue reading Q&A
This post has a summary of press coverage about results from a research study from Flatiron Health and Yale, following the Plenary Session presentation at ASCO 2019. We learned that Affordable Care Act (ACA) Medicaid expansion was associated with reduction in racial disparity in timely treatment of advanced cancer. Results were reported in the The … Continue reading Press: ACA Medicaid expansion eliminated racial disparities in timely cancer treatment
New paper in Vaccine shows staggered age targeting and the durability of protection will be key to strategic and efficient vaccination in South Africa. When an HIV vaccine is ready to launch in South Africa, an efficient implementation strategy needs to be ready. I worked with 3 women scientists in South Africa, 3 academic men … Continue reading Population targets and vaccine durability in South Africa
Want to join our book club? We’re reading the new Causal Inference Book by Miguel Hernan and James Robins. The book is forthcoming publication by Chapman & Hall/CRC and it is available for FREE right now to download from Harvard. Every few weeks my colleagues and I meet up to discuss a few chapters. We … Continue reading Causal Inference Book Club
There is little prior evidence of effective interventions to improve viral suppression, despite this being a critical step in the HIV care continuum as described in the National HIV/AIDS Strategy for the United States. Continue reading Should we pay some people to take their HIV drugs?
@AcademyHealth #ARM2018 attendees: join me on Monday at 3:15 pm in room 605-606, where Anirban Basu will present our work in collaboration with the Patient Centered Outcomes Research Institute (PCORI) to quantify the potential economic impact of the findings from comparative-effectiveness research studies. Goal Our goal was to understand the potential benefits of implementing comparative-effectiveness … Continue reading Economic Impact of Comparative-Effectiveness Studies